By using our website you accept our cookies policy.Find out more

Gain industrially relevant skills by working in synthetic biology companies

Posted on 29/01/2019

The Bristol BioDesign Institute's call for Innovation Placements will give ECRs the experience of working in growing synthetic biology companies.

Early career researchers (ECRs) are being offered the opportunity to gain experience of the innovative and dynamic environment of a rapidly growing synthetic biology spinout company, by taking part in an Innovation Placement.

The Bristol BioDesign Institute (BBI) has been awarded funding by BBSRC to support six Innovation Placements which will help ECRs to obtain industrially relevant skills by working in synthetic biology companies. These awards will cover salary costs for approximately 3 months, travel, subsistence, and other associated costs, up to a value of £20,000.

The six companies who have offered to host Innovation Placements are:

–  CytoSeek: Cell therapy spin-out company from the University of Bristol

–  Imophoron: Bristol-based synthetic biology start-up company

–  Rosa Biotech: Expected incorporation in early 2019, based in Bristol

–  Zentraxa: University of Bristol spin-out company

–  LabGenius: AI-driven synthetic biology start-up in London

–  OxSyBio: Synthetic biology company in Oxford

Applications must be submitted by Friday 15 February 2019. Further details on the placements on offer and how to apply can be found here.

Related Content

Quantum computing in the pharmaceutical industry, 14 March, Cambridge
KTN, in partnership with the Newton Gateway to Mathematics, is hosting a workshop on the potential of quantum computing in the pharmaceutical sector.
Supporting business growth and productivity in life sciences
The STFC B4I Life Sciences event on 26th March aims to help companies access a range of world-class science facilities using B4I funding.